A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation

Nicotine and Tobacco Research

Volumn 7, Issue 5, 2005, Pages 809-813

  White, William D ^a,c   Crockford, David ^a   Patten, Scott ^b   el Guebaly, Nady ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; GABAPENTIN; NICOTINE;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; MALE; MENTAL CONCENTRATION; OPEN STUDY; OUTCOMES RESEARCH; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SIDE EFFECT; SLEEP DISORDER; SMOKING CESSATION; STOMACH DISEASE; SUSTAINED RELEASE FORMULATION; TACHYCARDIA; TREMOR; VIVID DREAM; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADOLESCENT; ADULT; AMINES; BUPROPION; CYCLOHEXANECARBOXYLIC ACIDS; DOPAMINE UPTAKE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; SAMPLE SIZE; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 28244446927     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200500259887     Document Type: Article

References (17)

1. Beck, A. T., & Steer, R. A. (1978). Beck Depression Inventory. Philadelphia, PA: Center for Cognitive Therapy.
2. Churchill, L., Dilts, R. P., & Kalivas, P. W. (1992). Autoradiographic localization of gamma-aminobutyric acid A receptors within the ventral tegmental area. Neurochemical Research, 17, 101.
3. Crockford, D., White, W. D., & Campbell, B. (2001). Gabapentin use in benzodiazepine dependence and detoxification [letter]. Canadian Journal of Psychiatry, 46, 287.
4. Curry, S. J., Wagner, E. H., & Grothaus, L. C. (1990). Intrinsic and extrinsic motivation for smoking cessation. Journal of Consulting and Clinical Psychology, 58, 310-316.
5. Dewey, S. L., Brodie, J. D., Gerasimov, M., Horan, B., Gardner, E. L., & Ashby, C. R., Jr. (1999). A pharmacologic strategy for the treatment of nicotine addiction. Synapse, 31, 76-86.
6. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
7. Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991). Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience, 41, 89-125.
8. Hurt, R. D., Sachs, D. P., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T., & Sullivan, P. M. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. The New England Journal of Medicine, 337, 1195-1202.
9. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., Fiore, M. C., & Baker, T. B. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine, 340, 685-691.
10. Kalivas, P. W., Churchill, L., & Klitenick, M. A. (1993). GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience, 57, 1047-1060.
11. Kuo, H.-W., Yang, J.-S., & Chiu, M.-C. (2002). Determination of urinary and salivary cotinine using gas and liquid chromatography and enzyme-linked immunosorbent assay. Journal of Chromatography B, 768, 297-303.
12. Myrick, H., Malcolm, R., Henderson, S., & McCormick, K. (2001). Gabapentin for misuse of homemade nicotine nasal spray [letter]. American Journal of Psychiatry, 158, 498.
13. Petroff, O. A., Hyder, F., Rothman, D. L., & Mattson, R. H. (2000). Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia, 41, 675-680.
14. Statistics Canada. (1999). Canadian Tobacco Use Monitoring Survey. Retrieved November 18, 2004, from www.statcan.ca/english/sdds/4440.htm#InfoSurvey
15. Taylor, C. P., Gee, N. S., Su, T. Z., Kocsis, J. D., Welty, D. F., Brown, J. P., Dooley, D. J., Boden, P., & Singh, L. (1998). A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research, 29, 233-249.
16. U.S. Department of Health and Human Services. (1989). COSTART: Coding symbols for thesaurus of adverse reaction terms (3rd ed.). Rockville, MD: Food and Drug Administration.
17. Watkins, S. S., Koob, G. F., & Markou, A. (2000). Neural mechanisms underlying nicotine addiction: Acute positive reinforcement and withdrawal. Nicotine & Tobacco Research, 2, 19-37.